HomeSLS • NASDAQ
add
Sellas Life Sciences Group Inc
Previous close
$2.03
Day range
$1.92 - $2.06
Year range
$0.83 - $2.48
Market cap
279.98M USD
Avg Volume
4.29M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.08M | -3.36% |
Net income | -6.79M | 4.46% |
Net profit margin | — | — |
Earnings per share | -0.06 | 40.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 44.32M | 110.74% |
Total assets | 51.56M | 94.51% |
Total liabilities | 5.92M | -44.17% |
Total equity | 45.63M | — |
Shares outstanding | 142.44M | — |
Price to book | 5.64 | — |
Return on assets | -42.23% | — |
Return on capital | -48.44% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -6.79M | 4.46% |
Cash from operations | -7.07M | 9.45% |
Cash from investing | — | — |
Cash from financing | 26.09M | 32.51% |
Net change in cash | 19.02M | 60.07% |
Free cash flow | -4.60M | 16.79% |
About
Founded
2006
Website
Employees
15
